Literature DB >> 27599385

Mortality in systolic heart failure revisited: Ischemic versus non-ischemic cardiomyopathy.

Deepakraj Gajanana1, Mahek Shah2, Parichart Junpapart2, Abel Romero-Corral2, Vincent M Figueredo2, Behnam Bozorgnia2.   

Abstract

Entities:  

Keywords:  Guideline directed medical therapy; Ischemic cardiomyopathy; Non-ischemic cardiomyopathy; Systolic heart failure

Mesh：

Substances：

Year:  2016        PMID： 27599385     DOI： 10.1016/j.ijcard.2016.08.316

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  7 in total

1.  Myocardial and Serum Galectin-3 Expression Dynamics Marks Post-Myocardial Infarction Cardiac Remodelling.

Authors:  Umesh C Sharma; Wassim Mosleh; Milind R Chaudhari; Rujuta Katkar; Brian Weil; Chris Evelo; Thomas R Cimato; Saraswati Pokharel; W Matthijs Blankesteijn; Gen Suzuki
Journal:  Heart Lung Circ       Date:  2016-12-19       Impact factor: 2.975

2.  Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry.

Authors:  Ramon Corbalan; Jean-Pierre Bassand; Laura Illingworth; Giuseppe Ambrosio; A John Camm; David A Fitzmaurice; Keith A A Fox; Samuel Z Goldhaber; Shinya Goto; Sylvia Haas; Gloria Kayani; Lorenzo G Mantovani; Frank Misselwitz; Karen S Pieper; Alexander G G Turpie; Freek W A Verheugt; Ajay K Kakkar
Journal:  JAMA Cardiol       Date:  2019-06-01       Impact factor: 14.676

3.  Correlation Between T Peak to End Interval and Left Ventricular Time to Peak Longitudinal Strain in Ischemic Cardiomyopathy Patients.

Authors:  Chaerul Achmad; Aditya Fahmi Prianda; Badai Bhatara Tiksnadi; Mohammad Iqbal; Giky Karwiky; Mega Febrianora
Journal:  Cardiol Res       Date:  2020-08-01

4.  Prevalence of non-acute ischaemic cardiomyopathy in a Pakistani cohort.

Authors:  Muhammad Salman Ghazni; Saba Aijaz; Rehan Malik; Asad Z Pathan
Journal:  Heart Asia       Date:  2019-03-25

5.  Serum Sulfhydryl Groups, Malondialdehyde, Uric Acid, and Bilirubin as Predictors of Adverse Outcome in Heart Failure Patients due to Ischemic or Nonischemic Cardiomyopathy.

Authors:  Celina Wojciechowska; Wojciech Jacheć; Ewa Romuk; Anna Ciszek; Patryk Bodnar; Tomasz Chwalba; Martyna Waliczek; Mariusz Gąsior; Piotr Rozentryt
Journal:  Oxid Med Cell Longev       Date:  2021-04-15       Impact factor: 6.543

6.  Ischemic Cardiomyopathy versus Non-Ischemic Dilated Cardiomyopathy in Patients with Reduced Ejection Fraction- Clinical Characteristics and Prognosis Depending on Heart Failure Etiology (Data from European Society of Cardiology Heart Failure Registries).

Authors:  Agata Tymińska; Krzysztof Ozierański; Paweł Balsam; Cezary Maciejewski; Anna Wancerz; Emil Brociek; Michał Marchel; Maria G Crespo-Leiro; Aldo P Maggioni; Jarosław Drożdż; Grzegorz Opolski; Marcin Grabowski; Agnieszka Kapłon-Cieślicka
Journal:  Biology (Basel)       Date:  2022-02-21

7.  Network Pharmacology Analysis and Experimental Verification Strategies Reveal the Action Mechanism of Danshen Decoction in Treating Ischemic Cardiomyopathy.

Authors:  Mengnan Liu; Gang Yuan; Gang Luo; Xin Guo; Mingtai Chen; Huayi Yang; Fan He; Tingfu Yang; Xinyue Zhang; Qibiao Wu; Hua Zhou; Sijin Yang
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-02       Impact factor: 2.650
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.